Real-time funding, M&A, exec moves & hiring — the signals that move deals
More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
Aurobindo Pharma's Apitoria buys 80% of A1 Biochem
PRIVATEJul 26, 2026•14 days ago
Acquiring Company
Aurobindo Pharma Limited
Acquired Company
A1 Biochem Group
United StatesHyderabadManufacturingBiotechnologyPharmaceuticalBiotechnologyPharmaceutical
Description
Aurobindo Pharma Limited's subsidiary, Apitoria Pharma, has acquired an 80% stake in A1 Biochem Group's CRO business for USD 17 million. This acquisition will enable Aurobindo to enhance its research and development capabilities while expanding its presence in the Active Pharmaceutical Ingredients market. The deal is expected to close within 90 to 120 days, pending regulatory approvals.
Company Information
Company
Aurobindo Pharma Limited
Location
United States
About
Aurobindo Pharma Limited is a Midcap Pharma stock engaged in the manufacturing and marketing of APIs, generic pharmaceuticals, and other related services.
United States
HyderabadManufacturingBiotechnologyPharmaceuticalBiotechnologyPharmaceutical